Correlation study between executive function and monoamine neurotransmitter of methamphetamine-dependent adolescents
10.3760/cma.j.cn371468-20230224-00090
- VernacularTitle:甲基苯丙胺依赖青少年执行功能与单胺类神经递质相关性研究
- Author:
Xihui JI
1
;
Ruili FAN
;
Lushi JING
;
Binbin WU
;
Ke XU
;
Weidong FU
Author Information
1. 成都医学院心理学院,成都 610500
- Keywords:
Adolescents;
Methamphetamine-dependent;
Executive function;
Neurotransmitter
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2023;32(11):1011-1017
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the characteristics of executive function and alterations in monoamine neurotransmitters in methamphetamine-dependent adolescents and to analyse the relationship between executive function and monoamine neurotransmitters.Methods:From January to March 2017, totally 50 female methamphetamine-dependent adolescents and 50 male methamphetamine-dependent adolescents were selected as the experimental group in two compulsory isolation drug rehabilitation centres in Sichuan Province, while normal adolescents (50 males and 50 females) matching the age and gender of the experimental group were recruited as the control group in a school.Executive function was tested by the N-back test, colour word interference test and Hanoita test, and serum levels of dopamine, 5-hydroxytryptamine, epinephrine and norepinephrine were measured using high-performance liquid chromatography with fluorescence detection.Statistical analysis was performed by SPSS 21.0 software.The t-test was used to compare the differences of executive function between the experimental group and control group, and Pearson correlation analysis was used to assess the correlation between executive functions and monoamine neurotransmitters in the experimental group. Results:The differences in the number of correct 0-back responses ((105.38±17.00) vs (114.05±5.29) ) and correct response time ((728.82±110.95) ms vs (652.24±89.88) ms), number of correct 2-back responses ((54.78±23.04) vs ( 74.01±12.01)) and correct response time ((585.74±245.35) ms vs (477.44±181.26) ms), the number of correct responses in the Stroop task ((29.68±7.19) vs (33.60±7.36)) and correct response time ((973.73±228.27) ms vs ( 916.11±98.54) ms), and the number of TOH movement steps ((99.42±32.83) vs (87.70±32.55)) were statistically significant in the experimental group compared to the control group(all P<0.05). In the experimental group, serum dopamine ((5.06±1.55) μg/mL vs (3.18±1.97) μg/mL), 5-hydroxytryptamine ((351.94±119.90) ng/mL vs (149.27±69.24) ng/mL), epinephrine ((555.66±225.55) ng/mL vs (129.20± 81.39) ng/mL), and norepinephrine ((3.63±0.96) ng/mL vs (2.03±0.64) ng/mL) were higher than those in the control group, all with statistically significant differences (all P<0.01). Correlation analysis of executive function with monoamine neurotransmitters showed that serum dopamine level in the experimental group was correlated significantly with the number of correct 0-back, 2-back responses, correct response time, and TOH movement steps ( r=-0.194, 0.170, -0.163, 0.198, 0.196, all P<0.05), 5-hydroxytryptamine level was negatively correlated with the number of correct 0-back, 2-back responses( r=-0.267, -0.375), and was positively correlated with correct response time ( r=0.243, 0.177). Adrenaline content was significantly correlated with the number of correct 0-back and 2-back responses, correct response time, and the number of correct Stroop test responses, correct response time ( r=-0.340, 0.212, -0.415, 0.170, -0.212, 0.178, all P<0.05). Norepinephrine level was correlated significantly with the number of correct 0-back responses, correct response times, correct 2-back responses, correct Stroop test responses, and TOH movement steps ( r=-0.245, 0.266, -0.291, -0.193, 0.226, all P<0.05). Conclusion:The executive function of methamphetamine-dependent adolescents is damaged to a certain extent and the content of monoamine neurotransmitter in serum is increased.There is a correlation between impairment in executive function and serum levels of monoamine neurotransmitters.